The Power Play by The Market Herald Releases Interviews With Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton Minerals, SWMBRD Sports, and BioVaxys Technology Corp.

VANCOUVER, BC / ACCESSWIRE / March 30, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton Minerals, SWMBRD Sports, and BioVaxys Technology Corp. on their latest news.

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Monarch Mining (TSX:GBAR) hits high-grade gold on Swanson Project

Monarch (GBAR) has yielded up to 184.5 g/t gold over 1.5 m from its Swanson Project. The result is included within 27.79 g/t gold over 10.18 m at a vertical depth of 195 m. An additional highlight includes 29.4 g/t gold over 1.2 m and 8.5 g/t gold over 0.52 m within a broader zone of 2.63 g/t gold over 18.52 m. CEO Jean-Marc Lacoste sat down with Dave Jackson to comment on the results.

For the full interview with Jean-Marc Lacoste and to learn more about Monarch Mining's news, click here.

How Vox (TSXV:VOX) unlocks value for investors

Vox is a precious metals royalty and streaming company with a portfolio of over 50 royalties and streams spanning eight jurisdictions. Since 2019, Vox has announced over 20 separate transactions to acquire over 45 royalties. CIO Spencer Cole sat down with Dave Jackson to discuss how Vox unlocks value for investors.

For the full interview with Spencer Cole and to learn more about Vox, click here.

Tocvan Ventures (CSE:TOC) announces initial drill results from its Pilar Au-Ag Project

Tocvan Ventures Corp. (TOC) has announced initial drill results from its Pilar Project in Sonora, Mexico. Nine drill holes have been completed totalling over 1,540 meters. Tocvan CEO Brodie Sutherland sat down with Dave Jackson to discuss the update.

For the full interview with Brodie Sutherland and to learn more about Tocvan Ventures' news, click here.

GeneTether Therapeutics (CSE:GTTX) completes IPO and announces CSE listing

GeneTether Therapeutics (GTTX) has successfully closed its initial public offering and concurrent non-brokered private placement. A total of 7,500,000 units were sold at a price of $0.60 per unit for aggregate gross proceeds of $4,500,000. The company's common shares are expected to commence trading on the CSE under the symbol GTTX on or about March 30, 2022. GeneTether CEO Roland Boivin sat down with Dave Jackson to discuss the news.

For the full interview with Roland Boivin and to learn more about GeneTether's news, click here.

Peloton Minerals (CSE:PMC) reports progress on the Boulder Property

Peloton Minerals Corporation (PMC) has reported substantial progress on the Boulder Copper Porphyry Project. Work on the property is being completed by Peleton subsidiary Celerity Mineral Corporation. Celerity plans call for extensive geophysical work in 2022, a public listing in 2022 and a 50,000 to 80,000 feet drill program in 2023. Ted Ellwood, CEO of Peleton Minerals sat down with Dave Jackson to discuss the news.

For the full interview with Ted Ellwood and to learn more about Peleton Minerals' news, click here.

SWMBRD Sports Inc. (CSE:SWIM) provides update on manufacturing preparations

SWMBRD Sports (SWIM) has announced that Tahe Outdoors has completed the process of milling the twin high capacity aluminum SWMBRD moulds. Having completed the milling process, the company is drawing nearer to the first production of Swimboards. Justin Schroenn, President and CEO of SWMBRD Sports Inc. sat down with Dave Jackson to discuss the company's progress.

For the full interview with Justin Schroenn and to learn more about SWMBRD Sports' news, click here.

BioVaxys (CSE:BIOV) expands cancer vaccine platform

BioVaxys Technology Corp. (BIOV) has expanded its cancer vaccine platform with BVX-0922. BioVaxys plans to advance an Investigator-Sponsored Clinical Trial Application (CTA) in the EU with the European Medicines Agency (EMEA) this year. Co-founder and Chief Medical Officer Dr. David Berd sat down with Dave Jackson to discuss the news.

For the full interview with David Berd and to learn more about BioVaxys' news, click here.

Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visit The Power Play by The Market Herald.

About The Market Herald

The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.

_{DISCLAIMER: Report Card Canada Media Ltd. ("Report Card") is a wholly-owned subsidiary of Market Herald Limited, an Australian company ("Market Herald"). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald's affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website - themarketherald.ca - is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone 'bad'. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their "Terms of Service" before engaging in any business or uploading any information.}

CONTACT:

The Market Herald
Brianna Anthony
brianna.anthony@themarketherald.ca
themarketherald.ca

SOURCE: The Market Herald